References
- American Psychiatric Association. Diagnostic and Statistical Manual4th edition. American Psychiatric Association, Washington, DC 1994
- Baldwin S, Anderson R. The cult of methylphenidate: clinical update. Critical Public Health 2000; 10(1)80–86
- Best D W. Impact of illicit substance activity on young people. Journal of Substance Misuse for Nursing, Health and Social Care 1997; 2(4)197–202
- Breggin P R. Talking back to Ritalin. Common Courage Press, Monroe, Maine 1998
- Breggin P R. Psychostimulants in the treatment of children diagnosed with ADHD: Part 1 - acute risks and psychological effects. Ethical Human Sciences and Services 1999; 1(1)13–34
- Department of Health. Prescription cost analysis. Government Statistical Service, Statistics Division, Branch SD1E. Department of Health. 1998
- Health Education Authority. A parent's guide to drugs and alcohol. Health Education Authority, London 1998
- Julien R M. A primer of drug action. A concise, nontechnical guide to the actions, uses, and side effects of psychoactive drugs. W.H. Freeman & Company, New York 1998
- Kewley G. Personal paper: Attention deficit hyperactivity disorder is underdiagnosed and undertreated in Britain. BMJ 1998; 316: 1594–1596
- Miller N, Millman R, Gold M. Amphetamines: pharmacology, abuse and addiction. Advances in Alcohol and Substance Abuse 1989; 8(2)53–69
- National Institutes of Health. Diagnosis and treatment of attention deficit hyperactivity disorder: program and abstracts. NIH Consensus Development Conference, Rockville, MD, 1998
- Pates R, Coombes N, Ford N. A pilot programme in prescribing dexamphetamine for amphetamine users (part 1). Journal of Substance Misuse for Nursing, Health and Social Care 1996; 2(1)80–84